Carotenoid Supplementation Research Articles

HDL receptor/Scavenger receptor B1-Scarb1 and Scarb1-like mediate the carotenoid-based red coloration in fish

Both carotenoids and pteridine pigments can produce colors ranging from red to yellow and participate in mate choice, antioxidant, and immunity processes in animals. Common carp (Cyprinus carpio) variants with red coloration have been selectively bred for more than a thousand years, yet the mechanism that regulates coloration remains poorly understood. Here we provided experimental evidence that the red coloration in common carp varieties was carotenoid-based and was regulated by the carotenoid transport genes Scarb1 and Scarb1-like (high density lipoprotein (HDL) receptor/ scavenger receptor B type 1, also known as SR-BI). We found that carotenoids rather than pteridine pigments were specific to whole red (WR) but absent in whole white (WW) Oujiang color common carp (Cyprinus carpio var. color). Scarb1 and its novel paralog gene Scarb1-like were the most significant carotenoid metabolism-related genes differentially expressed between WR and WW, whereas no difference was detected for the Gch1 (GTP cyclohydrolase 1) gene, which acted as a rate limiting enzyme in the pteridine pathway. Disruption of Scarb1, Scarb1-like, and Gch1 using CRISPR/Cas9 technology resulted in regional red skin fading into white color in Scarb1 and Scarb1-like mutated WR (S+/−), leading to a decrease and a complete loss of astaxanthin and lutein in the red and white areas, respectively. However, no skin color variations were observed in Gch1 mutated WR fishes. In addition, disruption of the two Scarb1 genes and Gch1 together in WR caused red color variations similar to those observed in S+/− WR. Finally, carotenoids supplementation recovered the red color but had poorly effects on the white color in S+/− WR. This study revealed a plausible molecular mechanism responsible for red and white body colors and may benefit selective breeding programs of ornamental and cultured fish.

A Systematic Review of Carotenoids in the Management of Diabetic Retinopathy.

Diabetic retinopathy, which was primarily regarded as a microvascular disease, is the leading cause of irreversible blindness worldwide. With obesity at epidemic proportions, diabetes-related ocular problems are exponentially increasing in the developed world. Oxidative stress due to hyperglycemic states and its associated inflammation is one of the pathological mechanisms which leads to depletion of endogenous antioxidants in retina in a diabetic patient. This contributes to a cascade of events that finally leads to retinal neurodegeneration and irreversible vision loss. The xanthophylls lutein and zeaxanthin are known to promote retinal health, improve visual function in retinal diseases such as age-related macular degeneration that has oxidative damage central in its etiopathogenesis. Thus, it can be hypothesized that dietary supplements with xanthophylls that are potent antioxidants may regenerate the compromised antioxidant capacity as a consequence of the diabetic state, therefore ultimately promoting retinal health and visual improvement. We performed a comprehensive literature review of the National Library of Medicine and Web of Science databases, resulting in 341 publications meeting search criteria, of which, 18 were found eligible for inclusion in this review. Lutein and zeaxanthin demonstrated significant protection against capillary cell degeneration and hyperglycemia-induced changes in retinal vasculature. Observational studies indicate that depletion of xanthophyll carotenoids in the macula may represent a novel feature of DR, specifically in patients with type 2 or poorly managed type 1 diabetes. Meanwhile, early interventional trials with dietary carotenoid supplementation show promise in improving their levels in serum and macular pigments concomitant with benefits in visual performance. These findings provide a strong molecular basis and a line of evidence that suggests carotenoid vitamin therapy may offer enhanced neuroprotective effects with therapeutic potential to function as an adjunct nutraceutical strategy for management of diabetic retinopathy.

Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial

PurposeTo evaluate macular pigment response to carotenoid supplementation in glaucomatous eyes.DesignDouble-masked, randomized, placebo-controlled clinical trial, the European Nutrition in Glaucoma Management Study (ClinicalTrials.gov identifier, NCT04460365).ParticipantsSixty-two participants (38 men, 24 women) with a diagnosis of open-angle glaucoma were enrolled. Forty-two were randomized to receive the active supplement, 20 participants were allocated to placebo.MethodsMacular pigment optical density (MPOD) was measured by autofluorescence using the Heidelberg Spectralis scanning laser ophthalmoscope. Macular pigment optical density volume within the central 6° of retinal eccentricity as well as MPOD at 0.23°, 0.51°, 0.74°, and 1.02° were recorded at baseline and at 6-month intervals over 18 months. Visual function was assessed using visual acuity, mesopic and photopic contrast sensitivity under glare conditions, photo stress recovery time, microperimetry, and Glaucoma Activities Limitation 9 questionnaire. Advanced glaucoma module scans of retinal nerve fiber layer thickness and ganglion cell complex thickness over the central 6° of retinal eccentricity also were completed at each study visit.Main Outcome MeasuresChange in MPOD after supplementation with 10 mg lutein, 2 mg zeaxanthin, and 10 mg meso-zeaxanthin or placebo over 18 months.ResultsA mixed-model repeated measures analysis of variance revealed a statistically significant increase in MPOD volume (significant time effect: F(3,111) = 89.31, mean square error (MSE) = 1656.9; P < 0.01). Post hoc t tests revealed a significant difference in MPOD volume at each study visit for the treatment group (P < 0.01 for all), but no change in the placebo group (P > 0.05 for all). A statistically significant increase in mesopic contrast sensitivity under glare conditions was noted at 18 months in the treatment group, but not placebo. No other structural or functional changes were observed. No serious adverse events were noted during the trial.ConclusionsMacular pigment can be augmented in glaucomatous eyes by supplementation with a formulation containing the carotenoids lutein, zeaxanthin, and meso-zeaxanthin. The greatest relative benefit was observed in those with the lowest baseline levels, but increases were noted across all participants and each retinal eccentricity. The potential benefits of MP augmentation for macular health in glaucoma merit further long-term evaluation.

The Effects of Carotenoids Supplementation to Broiler Diets on Performance, Carcass and Some Blood Parameters

Amaç: Bu çalışmanın amacı, Çankırı İli’nde yetiştirilen Akkaraman sürülerinde doğumdan 18 aylık yaşa kadar bazı çevre faktörlerinin etkileri de dikkate alınarak gelişimlerinin belirlenmesidir.&#x0D; Materyal ve Yöntem: Bu çalışmanın hayvan materyali, Çankırı İli’nde yetiştirilen Akkaraman koyunlardan oluşmaktadır. Çalışma 2018 yılı Ocak, Şubat ve Mart aylarında 4 farklı işletmede doğan toplam 208 kuzu üzerinde gerçekleştirilmiştir. Çalışmada Akkaraman koyunların doğum ile 3, 6, 12 ve 18 aylık dönemlerdeki canlı ağırlıkları belirlenmiştir.&#x0D; Bulgular: Çalışmada doğum, 3, 6, 12 ve 18 aylık dönemlerde ortalama canlı ağırlıklar sırasıyla 3.874 kg, 31.441 kg, 41.001 kg, 42.228 kg ve 55.528 kg olarak bulunmuştur. Cinsiyetin etkisi istatistiksel olarak 6, 12 ve 18 aylık dönemlerde önemli (p

Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4−/−/Bco2−/− double knockout mice

Accumulation of bisretinoids such as A2E and its isomer iso-A2E is thought to mediate blue light-induced oxidative damage associated with age-related macular degeneration (AMD) and autosomal recessive Stargardt disease (STGD1). We hypothesize that increasing dietary intake of the macular carotenoids lutein and zeaxanthin in individuals at risk of AMD and STGD1 can inhibit the formation of bisretinoids A2E and iso-A2E, which can potentially ameliorate macular degenerative diseases. To study the beneficial effect of macular carotenoids in a retinal degenerative diseases model, we used ATP-binding cassette, sub-family A member 4 (Abca4−/−)/β,β-carotene-9′,10′-oxygenase 2 (Bco2−/−) double knockout (KO) mice that accumulate elevated levels of A2E and iso-A2E in the retinal pigment epithelium (RPE) and macular carotenoids in the retina. Abca4−/−/Bco2−/− and Abca4−/− mice were fed a lutein-supplemented chow, zeaxanthin-supplemented chow or placebo chow (~2.6 mg of carotenoid/mouse/day) for three months. Visual function and electroretinography (ERG) were measured after one month and three months of carotenoid supplementation. The lutein and zeaxanthin supplemented Abca4−/−/Bco2−/− mice had significantly lower levels of RPE/choroid A2E and iso-A2E compared to control mice fed with placebo chow and improved visual performance. Carotenoid supplementation in Abca4−/− mice minimally raised retinal carotenoid levels and did not show much difference in bisretinoid levels or visual function compared to the control diet group. There was a statistically significant inverse correlation between carotenoid levels in the retina and A2E and iso-A2E levels in the RPE/choroid. Supplementation with retinal carotenoids, especially zeaxanthin, effectively inhibits bisretinoid formation in a mouse model of STGD1 genetically enhanced to accumulate carotenoids in the retina. These results provide further impetus to pursue oral carotenoids as therapeutic interventions for STGD1 and AMD.

Pigment Production under Cold Stress in the Green Microalga Chlamydomonas reinhardtii

Microalgae have long been used for the commercial production of natural colorants such as carotenoids and chlorophyll. Due to the rising demand for carotenoids and other natural products from microalgae, strategies to increase production efficiency are urgently needed. The production of microalgal biorefineries has been limited to countries with moderate climates. For countries with cooler climates and less daylight, methodologies for the efficient production of microalgal biorefineries need to be investigated. Algal strains that can be safely consumed as whole cells are also attractive alternatives for developing as carotenoid supplements, which can also contain other compounds with health benefits. Using such strains helps to eliminate the need for hazardous solvents for extraction and several other complicated steps. In this study, the mesophilic green alga Chlamydomonas reinhardtii was employed to study the effects of cold stress on cell physiology and the production of pigments and storage compounds. The results showed that temperatures between 10 and 20 °C induced carotenoid and chlorophyll accumulation in the wild-type strain of C. reinhardtii. Interestingly, the increased level of carotenoids suggested that they might play a crucial role in cold stress acclimation. A temperature of 15 °C resulted in the highest carotenoid and chlorophyll productivity. At this temperature, carotenoid and chlorophyll productivity was 2 times and 1.3 times higher than at 25 °C, respectively. Subjecting a mutant defective in lutein and zeaxanthin accumulation to cold stress revealed that these two carotenoids are not essential for cold stress survival. Therefore, cold temperature could be used as a strategy to induce and increase the productivity of pigments in C. reinhardtii.

Carotenoids in Milk and the Potential for Dairy Based Functional Foods.

Carotenoids are a family of over 1100 known natural pigments synthesized by plants, algae, fungi and bacteria. Dietary intake of carotenoids is necessary for mammals as they cannot be synthesized in the body. In cows, the nature of the diet consumed strongly influences the composition of milk produced and this includes carotenoid concentration and profile. Fresh forage is the richest source of carotenoids for cows. The main carotenoids identified in forages are lutein, β-carotene, zeaxanthin and epilutein. Manipulating cow feed via carotenoid supplementation increases the carotenoid content of bovine milk. In humans, carotenoids have anti-oxidant, anti-inflammatory and provitamin A activity. Lutein is a major carotenoid in human milk and the brain tissue of adults and infants. Lutein and zeaxanthin are linked to improved eye health and cognitive function. Traditionally for humans, fruit and vegetables have been the main source of carotenoid intake. Functional foods present an opportunity to incorporate these naturally occurring compounds into milk products for added health benefits, widening the range of dietary sources of carotenoids. We offer an overview of the literature to date on carotenoid-fortified dairy products and infant formula. This review will describe and summarize the key mechanisms by which the carotenoid profile of bovine milk can be manipulated. We present findings on the origin and role of carotenoids in bovine and human milk, outline factors that impact the carotenoid content of milk, evaluate carotenoid-fortified milk products and discuss the associated challenges, such as bioaccessibility and stability.

Mechanistic aspects of carotenoid health benefits - where are we now?

Dietary intake and tissue levels of carotenoids have been associated with a reduced risk of several chronic diseases, including cardiovascular diseases, type 2 diabetes, obesity, brain-related diseases and some types of cancer. However, intervention trials with isolated carotenoid supplements have mostly failed to confirm the postulated health benefits. It has thereby been speculated that dosing, matrix and synergistic effects, as well as underlying health and the individual nutritional status plus genetic background do play a role. It appears that our knowledge on carotenoid-mediated health benefits may still be incomplete, as the underlying mechanisms of action are poorly understood in relation to human relevance. Antioxidant mechanisms - direct or via transcription factors such as NRF2 and NF-κB - and activation of nuclear hormone receptor pathways such as of RAR, RXR or also PPARs, via carotenoid metabolites, are the basic principles which we try to connect with carotenoid-transmitted health benefits as exemplified with described common diseases including obesity/diabetes and cancer. Depending on the targeted diseases, single or multiple mechanisms of actions may play a role. In this review and position paper, we try to highlight our present knowledge on carotenoid metabolism and mechanisms translatable into health benefits related to several chronic diseases.

Effects of Linseed Meal and Carotenoids from Different Sources on Egg Characteristics, Yolk Fatty Acid and Carotenoid Profile and Lipid Peroxidation.

The present study aimed to evaluate the effect of supplementing the diet of laying hens with linseed meal and carotenoids from different sources on egg characteristics, yolk fatty acid and carotenoid profile, and lipid peroxidation. A 4-week experiment was conducted on 168 Lohmann Brown layers (43 weeks of age), assigned to four dietary treatments (42 hens/group; 21 replicate/groups with 2 birds/pen) consisting of a control diet (C) and three diets simultaneously supplemented with 6% linseed meal and 2% dried kapia pepper (E1), 2% dried sea buckthorn pomace (E2) and 2% dried carrot (E3). Every 2 weeks, 18 eggs/group/period were collected randomly from each group and used to determine the egg quality and nutritional parameters. The results showed that dietary linseed meal and carotenoids sources improved egg color, carotenoids’ accumulation in egg yolk and fatty acid profile, especially the n-3 PUFA content. Dietary carotenoids supplementation reduced, n-6/n-3 ratio, cholesterol content of the egg yolk and improved yolk pH, egg thickness and yolk oxidative stability. In conclusion, the use of these sources of carotenoids in the linseed meal enriched diets could be an effective way to improve the nutritional properties of the eggs without affecting their quality and consumer’s safety.

Role of ingestible carotenoids in skin protection: A review of clinical evidence.

Carotenoids, a class of phytonutrients, have been well established to boost skin's innate resistance against ultraviolet (UV) B-induced erythema (sunburn). Many of the published clinical studies thus far have focused on the measurement of erythema as the primary clinical indicator of skin protection against UVB radiation. More recent studies have shown that carotenoid supplementation provides even more skin protection than previously shown as new clinical and molecular endpoints beyond UVB-induced erythema have been reported. These recent studies have demonstrated that carotenoids also provide photoprotection against UVA-induced pigmentation and inhibit molecular markers of oxidative stress such as intercellular adhesion molecule 1, heme oxygenase-1, and matrix metalloproteinases 1 and 9. This article provides a comprehensive review of the published clinical evidence on skin benefits of carotenoids in the last five decades and indicates new perspectives on the role of ingestible carotenoids in skin protection.

The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study\u2014carotenoid supplementation during pregnancy: ocular and systemic effects\u2014study protocol for a randomized controlled trial

BackgroundLutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ), collectively called the macular pigment (MP), are dietary carotenoids that preferentially localize in the macula of the human eye. MP protects the macula from photo-oxidative damage and enhances visual function. Inadequate maternal intake of carotenoids, coupled with the placental transfer of maternal carotenoids to support fetal brain and retina development, potentially put mothers at risk of depletion systemically and in their ocular tissues. Presently, maternal carotenoid status throughout pregnancy remains poorly characterized, and no prospective randomized controlled trial of L and Z supplementation via prenatal vitamins has assessed maternal and infants’ systemic and ocular carotenoid status during pregnancy. We hypothesize that prenatal maternal carotenoid supplementation will counteract maternal carotenoid depletion during pregnancy and will improve biomarkers of carotenoid status of both mothers and infants.MethodsLutein and Zeaxanthin in Pregnancy (L-ZIP) is a phase 2, single-center, prospective, double-masked, randomized active-controlled clinical trial conducted at the John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA. Participants consume a daily standard prenatal multivitamin with no added carotenoids and are randomized (1:1 allocation) to receive either a capsule containing 10 mg L and 2 mg Z in safflower oil (Carotenoid group) or a capsule containing only safflower oil with no added carotenoids (Control group) for a period of 6 to 8 months. Skin, serum, and ocular carotenoids are measured at every study visit (i.e., within the first trimester [baseline], second trimester, third trimester, and 0–2 weeks postpartum). Skin carotenoid assessment is by resonance Raman spectroscopy (RRS); serum carotenoid status is quantified using high-performance liquid chromatography (HPLC); and MP is measured with the dual-wavelength autofluorescence. Infants’ MP and foveal anatomy are assessed using RetCam retinal camera and Bioptigen SD-OCT, respectively. The primary outcomes are changes in maternal systemic and ocular carotenoid status during pregnancy.DiscussionL-ZIP is the first prospective RCT to investigate maternal carotenoid status throughout pregnancy and to determine whether prenatal maternal carotenoid supplementation will offset maternal carotenoid depletion and improve biomarkers of maternal and infant’s carotenoid status. Findings from L-ZIP will strengthen recommendations regarding prenatal carotenoid supplementation and consequently inform policy decisions.Trial registrationClinicalTrials.gov NCT03750968. Registered on November 23, 2018

Effect of different levels of synthetic astaxanthin on growth, skin color and lipid metabolism of commercial sized red porgy (Pagrus pagrus)

A study was undertaken to evaluate the effects of supplementing commercial feeds with Carophyll® Pink, a gelatin-encapsuled astaxanthin, on growth parameters, lipid composition, pigment concentration and skin color of commercial size red porgy. Three isonitrogenous diets were formulated containing different levels of astaxantin: Ctrl diet (no pigment added), A50 diet (with 50 mg/kg of astaxanthin) and A80 diet (with 80 mg/ kg of astaxanthin). Four groups of fish (386.29 ± 29.50 g initial weight) were grown in triplicate tanks (10 fish per tank). Ctrl, A50 and A80 groups were fed the respective diets to apparent satiation for 180 days, while a fourth group was fed A50 diet for 90 days followed by A80 diet for another 90 days (A50A80). At the end of trial muscle samples were collected for composition analysis, liver and mesenteric fat for lipid composition determination and skin samples for carotenoids quantification. Dietary astaxanthin supplementation had no effect on growth performance and hepatosomatic index. However, A50A80 group displayed a lower muscle protein content and higher fat content when compared to the other groups. There was no clear effect of dietary astaxanthin supplementation on the liver’s and mesenteric fatty acid profile. Although there was no significant effect on skin total carotenoids, the astaxanthin content tended to increase in fish fed astaxanthin supplemented diets, which was reflected on redness values. Accordingly, dietary astaxanthin supplementation (at 50 or 80 mg/kg for 6 months or at 50 mg/kg for 3 months followed by 80 mg/kg for 3 months) influenced positively skin hue and chroma of red porgy on both pectoral and caudal areas, improving the skin color in commercial sized red porgy and achieving hue and chroma values close to those previously reported for wild individuals. The results reported here provide evidence of the applicability of Carophyll® Pink to improve skin color of large size commercial red porgy, but further studies are needed to optimize this carotenoid supplementation in production farming.

Carotenoids and Cognitive Outcomes: A Meta-Analysis of Randomized Intervention Trials.

Recent evidence suggests that diet can modify the risk of future cognitive impairment and dementia. A biologically plausible rationale and initial clinical data indicate that the antioxidant activities of dietary carotenoids may assist the preservation of cognitive function. A meta-analysis of randomized controlled trials was conducted to examine the relationship between carotenoid supplementation and cognitive performance. A literature search was conducted in the MEDLINE (via PubMed), Scopus, Web of Science, and Cochrane databases from their inception to July 2020. A total of 435 studies were retrieved. screening using predefined inclusion and exclusion criteria was followed by full-text screening and data extraction of study characteristics and measured outcomes. A meta-analysis of eligible trials was performed using a random-effects model to estimate pooled effect size. We identified 9 studies with a total of 4402 nondemented subjects, whose age ranged from 45 to 78 years. Results of the pooled meta-analysis found a significant effect of carotenoid intervention on cognitive outcomes (Hedge’s g = 0.14; 95% confidence interval: 0.08, 0.20, p < 0.0001). There was no evidence of heterogeneity among the studies (τ2 = 0.00, I2 = 0.00%, H2 = 1.00) or publication bias. Although further studies are needed, our results suggest that carotenoid interventions are associated with better cognitive performance. Thus, these dietary compounds may help to reduce the risk of cognitive impairment and dementia.

Mixed carotenoid supplementation and dysmetabolic obesity: gaps in knowledge

Dysmetabolic obesity during childhood and adolescence currently represents one of the greatest therapeutic challenge for healthcare systems worldwide. The global rates of obesity have more than doubled in the last 30 years. Recent meta-analysis from national surveys and food composition studies suggest an inverse association between lower carotenoid levels and the prevalence of Metabolic Syndrome in the general population, independent of serum retinol (vitamin A) levels. In children, two double-blind randomised placebo-controlled studies describing the effects of diet vs. mixed carotenoid supplementation on insulin resistance, adipokines and the rate of accrual of subcutaneous abdominal fat, implicate supplementation of these compounds to achieve targetable levels may be useful in the management of obesity accrual in this population. We will discuss the role of carotenoids and their conversion products (retinoids) in adipogenesis, lipolysis, insulin resistance and the pathophysiology of the metabolic syndrome and review the animal studies, which help support these findings.

13035 Multiple carotenoids supplementation enhances human skin protection against ultraviolet A–induced skin pigmentation: A randomized, double-blind, placebo-controlled clinical trial

Extrinsic photoprotection of human skin is determined by the efficacy of sunscreens to prevent ultraviolet (UV) B radiation-induced erythema and UVA radiation-induced pigmentation. In addition to externally applied sunscreens, oral supplementation of carotenoids has been clinically shown to protect human skin against ultraviolet B (UVB) radiation-induced erythema (sunburn). It is not known if this is also the case for UVA radiation-induced pigmentation. The main objective of this research was to clinically evaluate the photoprotective effects of daily supplementation with carotenoids against UVA radiation-induced pigmentation, in addition to UVB-induced erythema.

Effects of different dietary supplementation of plant carotenoids on growth, coloration and behaviour of giant gourami, Trichogaster fasciata (Bloch and Schneider, 1801)

Effects of different dietary supplements of plant carotenoid sources on growth, coloration and behavioural activities of Trichogaster fasciata were carried out. Three groups of fish were fed with petal powder of rose (Rosa chinensis), China rose (Hibiscus rosasinensis) and marigold (Tagetes erecta) separately as carotenoid source along with the same basic ingredients for 90 days. The mean final weight of marigold petal powder fed group was significantly different (p <0.05) from other groups after 90 days of the experiment. The absolute growth rate, relative growth rate, weight gain percent and specific growth rate were highest in the group of fish fed with marigold petal powder while feed conversion ratio was lowest in this group. Carotenoid content in the tissue of different groups of the fish was found to be significantly different (p <0.0001). Marigold petal powder was most effective to enhance the pigmentation and coloration in the different color zones (color of eye and opercular ocellus, jugular darkening, anal, ventral and dorsal fin color etc.) of the skin of T. fasciata. Pigmentation affected the behavioural activities of the fish where male aggression and selection of males by females was high in the group fed with marigold petal powder. No significant difference was observed in the social interactions and habitat preference.

Carotenoid feed supplementation in Argentine penaeoid shrimp broodstock

This work aimed to improve reproductive maturation in two penaeoid species (Artemesia longinaris and Pleoticus muelleri) by using carotenes added in artificial feeds and comparing antioxidant activity and carotenoids profiles. Immature females were kept for 45 days at salinity 33, temperature at 18°C, pH 7, 12:12 h photoperiod, ammonium &lt;0.2mg L-1 and seawater exchanged at 100% per day. Feeding regimes consisted of 50% fresh frozen ingredients (clam muscle and squid mantle) and 50% dry pellets. For each species, three pelletized feeds were tested, one as a control (C) and two supplemented each one with 300 mg astaxanthin (A) and β-carotene (B) kg-1 of diet. At the end of the trials, ovaries, midgut gland, and integument were sampled. In both species, the addition of carotenoids improved ovarian development: 100% of females fed A or B diets were mature, but of the females fed with diet C only 75% (P. muelleri) and 64% (A. longinaris) matured. Ovaries of mature females exhibited the highest concentration of carotenoids. The abundance of free astaxanthin regarding total carotenes, suggests that excess of free astaxanthin could be biotransformed to esterified astaxanthin. The scavenging properties were evaluated against the stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical by electron resonance spectroscopy (EPR). For all feed treatments, the extracts exhibited strong DPPH scavenging activity, without significant differences among them.

Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.

Purpose: To compare the changes in visual and ocular parameters in individuals with retinal drusen who were treated with two commercially available nutritional supplements. Methods: An open-label, single-center, randomized, parallel-treatment with an observational control group design was utilized. The treatment groups included individuals with fine retinal drusen sub-clinical age-related macular degeneration (AMD), while the control group consisted of ocular normal individuals. The treatment groups were randomly assigned to the micronized lipid-based carotenoid supplement, Lumega-Z (LM), or the PreserVision Age-Related Eye Disease Study 2 (AREDS-2) soft gel (PV). Visual performance was evaluated using the techniques of visual acuity, dark adaptation recovery and contrast sensitivity, at baseline, three months, and six months. Additionally, the macular pigment optical density (MPOD) was measured. The control group was not assigned any carotenoid supplement. The right eye and left eye results were analyzed separately. Results: Seventy-nine participants were recruited for this study, of which 68 qualified and 56 participants had useable reliable data. Of the individuals who completed this study, 25 participants belonged to the LM group, 16 belonged to the PV group, and 15 to the control group. The LM group demonstrated statistically significant improvements in contrast sensitivity function (CSF) in both eyes at six months (p < 0.001). The LM group displayed a positive linear trend with treatment time in CSF (p < 0.001), with benefits visible after just three months of supplementation. Although there was a trend showing improvement in CSF in the PV group, the change was not significant after a Bonferroni-corrected p-value of p < 0.00625. Visual acuity, dark adaptation recovery and MPOD did not significantly improve in either treatment groups. Conclusion: The LM group demonstrated greater and faster benefits in visual performance as measured by CSF when compared to the PV group. This trial has been registered at clinicaltrials.gov (NCT03946085).

Effects of paprika carotenoid supplementation on bone turnover in postmenopausal women: a randomized, double-blind, placebo-controlled, parallel-group comparison study.

BackgroundPaprika (Capsicum annuum L.) is a good source of carotenoids, including capsanthin, β-carotene, β-cryptoxanthin, and zeaxanthin. Several epidemiological studies have shown a beneficial association of intake of these carotenoids or their blood concentration with bone mineral density (BMD) and fracture risk. However, little information is available regarding the effect of intake of these carotenoids on bone metabolism in postmenopausal women.ObjectiveThe objective of the present study was to investigate the effects of paprika carotenoid extract (PCE) on bone turnover in healthy, postmenopausal women.DesignWe conducted a randomized, double-blind, placebo-controlled, parallel-group comparison study. One hundred participants were randomly assigned to PCE or placebo groups. Each group was given a 20 mg PCE (equivalent to 1.4 mg of carotenoids) a day or a placebo for 24 weeks. We measured bone resorption markers (tartrate-resistant acid phosphatase 5b [TRACP-5b] and serum type I collagen cross-linked N-telopeptide [sNTX]) at 12 and 24 weeks and bone formation markers (bone alkaline phosphatase and osteocalcin) at 24 weeks.ResultsThe percentage decrease of TRACP-5b at 24 weeks was significantly higher for PCE than the placebo. There were no significant differences in sNTX or bone formation markers, although PCE decreased each marker compared with the placebo.ConclusionOur findings suggest that PCE supplementation suppresses bone resorption and contributes to maintaining bone quality in postmenopausal women.

Effect of natural pigment sources on colouration of red zebra cichlid ( Maylandia estherae Konings, 1995)

This study was done to assess the effect of the colouration of the red zebra cichlid (Maylandia estherae), using beet root red (Beta vulgaris ruba) and henna (Lawsonia inermis). The fish with an average weight of 1.21 ± 0.69 g was placed in 12 aquariums. Fifteen fish were placed in each aquarium. The fish were fed with diets which were without carotenoid supplement (AK), containing astaxanthin (AA), beet root red (AP) and henna (AI). Except the AK, each group contained 50 mg/kg carotenoid additives. As a result of the experiment, total carotenoid values between groups were not significant (p > .05). The redness (a*) value of groups was significant (p < .05), and the values of brightness (L*) and yellowness (b*) were not significant (p > .05). Samples were kept in the freezer at −20°C for 120 days to see whether the fish kept their colour. All groups decreased compared with the 50th day. This difference in groups except the AP was significant (p < .05). The FCR, SGR and weight gain% was not significant (p > .05). The survival was 97.28%, and it was the same in all groups. The study concluded that natural carotene sources with lower costs had similar effects with astaxanthin.